Sign in to continue:

Thursday, March 5th, 2026

Charging Robotics Inc. Announces $2 Million Private Placement of Common Stock and Pre-Funded Warrants – Securities Purchase Agreement Details





Charging Robotics Inc. Announces Private Placement Offering and Key Corporate Developments

Charging Robotics Inc. Enters Securities Purchase Agreement: Private Placement and Potential Uplisting to Nasdaq

Key Highlights for Investors

  • Private Placement Offering Announced: Charging Robotics Inc. has entered into a securities purchase agreement with accredited investors for a private placement of up to 500,000 shares of Common Stock or pre-funded warrants at \$4.00 per share (or \$3.9999 per pre-funded warrant).
  • Strategic Uplisting to Nasdaq: The closing of the private placement is contingent on the company’s successful uplisting to a national securities exchange, specifically the Nasdaq Stock Market LLC.
  • Use of Proceeds: Net proceeds from this offering will be used for general corporate purposes, including potential acquisitions, working capital, and repayment of debt, at the company’s discretion.
  • Unregistered Securities: The securities offered in this placement are unregistered and are being issued under exemptions for accredited investors or qualified institutional buyers. They cannot be sold in the U.S. without registration or an applicable exemption.
  • Forward-Looking Statements: The company has issued cautionary statements about forward-looking statements, noting that closing is subject to various customary conditions, final due diligence, execution of definitive agreements, stockholder approval, and other contingencies.
  • No Existing Trading Symbol: As of the date of the report, Charging Robotics Inc. does not have an active trading symbol or exchange listing, but the uplisting to Nasdaq is expected to change this situation.
  • Material Agreements Filed: Full texts of the Purchase Agreement, Pre-Funded Warrant, and Registration Rights Agreement have been filed as exhibits and are available for review.
  • Emerging Growth Company Status: Charging Robotics Inc. is classified as an emerging growth company under SEC rules, which may impact compliance obligations and disclosure requirements.

Details of the Private Placement

On March 4, 2026, Charging Robotics Inc. announced the execution of a securities purchase agreement with certain accredited investors. The company agreed to sell and issue up to 500,000 shares of Common Stock, or alternatively, pre-funded warrants to purchase shares of Common Stock. The offering price is set at \$4.00 per share and \$3.9999 per pre-funded warrant, allowing flexibility for investors seeking to avoid certain regulatory thresholds or tax implications.

The transaction structure enables qualified investors to choose between direct equity ownership or pre-funded warrants, which are exercisable immediately and expire upon exercise in full. These warrants facilitate investment for those who want to manage ownership percentages or avoid triggering beneficial ownership reporting requirements.

All securities offered in this placement are being issued in reliance on exemptions from SEC registration under Regulation D and Rule 144A. This means they are restricted securities and not freely tradable in the public market without further registration or qualifying for another exemption.

Contingencies and Closing Conditions

  • Nasdaq Uplisting Condition: The closing of the private placement is specifically conditioned upon the company’s Common Stock being approved for listing on the Nasdaq Stock Market LLC.
  • Customary Closing Conditions: Additional requirements include satisfactory completion of final due diligence, execution and delivery of all transaction documents, stockholder approval if required, and the absence of any material adverse effect on the company prior to closing.
  • Market Stability: The agreement stipulates that trading in the company’s securities must not be suspended or materially adversely affected in the broader market prior to closing.

Forward-Looking Statements and Risks

The company’s report includes extensive cautionary language regarding forward-looking statements. Management warns that the private placement and uplisting to Nasdaq are subject to multiple uncertainties and contingencies, some of which are beyond the company’s control. Investors are advised not to place undue reliance on these forward-looking statements, as there is no guarantee that the transactions will be completed as planned.

Other Material Terms and Shareholder Considerations

  • Restricted Securities and Resale Limitations: The securities may only be transferred in compliance with applicable securities laws. Certificates will bear restrictive legends unless and until they are registered or sold pursuant to an exemption.
  • Registration Rights: Investors in the private placement will benefit from a Registration Rights Agreement, obligating the company to register the resale of these securities, which could facilitate future liquidity for investors.
  • No General Solicitation: The offering was conducted without general solicitation or advertising, strictly to accredited or qualified institutional investors.
  • Lock-up Provisions: For sixty (60) days following the release date, the company is restricted from issuing additional equity or registering other securities, except in limited exempt cases (such as employee stock plans).
  • Use of Proceeds: Although the company retains broad discretion, the explicit mention of acquisitions and debt repayment signals a possible shift in strategy or capital allocation, which could have significant implications for future growth or financial stability.
  • Compliance and Corporate Governance: Charging Robotics Inc. affirms compliance with Sarbanes-Oxley, internal accounting controls, and ongoing reporting obligations. The company’s accounting firm is Brightman Almagor Zohar & Co. (Deloitte network), and legal counsel is Greenberg Traurig, P.A.
  • Anti-Takeover and Shareholder Rights: The company confirms that purchasers in this offering will not trigger any anti-takeover provisions or be deemed “Acquiring Persons” under any poison pill or similar plans.

Potential Price-Sensitive Information

Investor Impact:

  • The successful closing of the private placement at a premium price (\$4.00/share) and a Nasdaq uplisting could significantly enhance the company’s liquidity, visibility, and access to capital, potentially driving share price appreciation once listed.
  • The issuance of unregistered shares or warrants, and the subsequent registration for resale, could impact future supply of shares and influence trading dynamics.
  • Any failure to meet the uplisting or closing conditions could be negatively received by investors and may result in downward pressure on valuation.

Executive Sign-off

The report was signed by Yakov Baranes, Chief Executive Officer of Charging Robotics Inc., on March 4, 2026, affirming the company’s commitment to transparency and regulatory compliance.

Conclusion

Charging Robotics Inc. is at a pivotal juncture, with the announced private placement and planned Nasdaq uplisting representing major corporate milestones. Investors should closely monitor further announcements regarding the closing of the private placement, the achievement of uplisting to Nasdaq, and the company’s use of proceeds. These developments could have a material impact on the valuation, trading liquidity, and strategic trajectory of Charging Robotics Inc.


Disclaimer: This article is provided for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with professional advisors before making investment decisions. The information herein is based on publicly available filings and may be subject to change or clarification in future disclosures by Charging Robotics Inc.




View Charging Robotics Inc. Historical chart here



Amneal Pharmaceuticals, Inc. 2025 Annual Report: Business Segments, License Agreements, and Related Party Transactions Overview

Amneal Pharmaceuticals, Inc. 2025 Annual Report – Key Investor Insights Amneal Pharmaceuticals, Inc. 2025 Annual Report: Key Investor Insights Overview Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX), headquartered in Bridgewater, NJ, has released its 2025 Annual...

Klotho Neurosciences Acquires Greenland Mines Corp., Securing $68 Billion Palladium-Gold Deposit and Strengthening Western Critical Mineral Supply 12345

Klotho Neurosciences Acquires Greenland Mines Corp: Transformational Asset for Shareholders Klotho Neurosciences Acquires Greenland Mines Corp: Transformational Asset for Shareholders Key Points of the Transaction Klotho Neurosciences, Inc. (Nasdaq: KLTO) has announced the acquisition...

Domo, Inc. Announces Strategic Alternatives Review and Reaffirms FY2026 Guidance

Domo, Inc. Initiates Strategic Alternatives Review and Reaffirms FY2026 Guidance Key Points: Domo, Inc.’s Board of Directors has announced the initiation of a formal process to explore strategic alternatives aimed at maximizing shareholder value....

   Ad